Vehicle ride comfort condition is evaluated by extending the advanced procedures as currently recommended in the ISO 2631-1 stondard thethe scenarios of multiple vehicles in the stochastic traffic flow, including obtaining the whole-body vibration response, frequency weighting the original response and determining the Overall Vibration Total Value OVTVValue OVTV
Vinflunine is recommended in the European guideline for the treatment of advanced or metastatic urothelial cell carcinoma (UCC) after failure of platinum-based therapy.
Pazopanib, sunitinib and bevacizumab (plus IFN-α) are recommended in the clinical guidelines for first-line treatment of advanced RCC in patients with favorable and intermediate risk [ 14- 16].
At present, EGFR gene copy number testing is not recommended in the selection of first- or second-line treatment of advanced NSCLC patients.
This method is recommended in the Advanced Trauma Life Support guidelines of the American College of Surgeons [ 17].
16, 23, 39 Mutational analysis for activating mutations is strongly recommended in all advanced GISTs because of their predictive value.
14, 39 Since it is more expensive to measure serum cys C than scr (approximately US $8.5 vs $0.75), 40 besides accuracy is unacceptable in moderately severely damaged kidney function elderly subjects, the Cscr-cys equation is not recommended in elderly with advanced kidney function.
External rotation osteotomy is recommended in advanced glenohumeral deformity with pseudoglenoid and posterior dislocation of the humeral head in older patients (Goddard and Fixsen 1984, Kirkos and Papadopoulos 1988, Al-Qattan 2002, Waters and Bae 2006, Bae and Waters 2007).
Periodic MRIs or CT scans may be recommended in advanced disease and women with a history of endometrial cancer should receive more frequent pelvic examinations for the five years following treatment.
Detection of KIT or PDGFRA mutations is recommended in advanced GISTs because they are highly predictive of tumor response to RTK inhibitors, as well as in KIT-negative cases to confirm diagnosis.
Based on these data, the National Institute of Clinical Excellence (NICE) in the United Kingdom recommended in 2001 the use of gemcitabine monotherapy for patients with advanced pancreatic cancer.
